Iconovo AB Sustainability Reports
Iconovo AB develops complete inhalation medicinal products, including proprietary inhaler devices and dry powder formulations, in collaboration with international pharmaceutical companies.
Sector: Professional & technical services
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 549300CH7SEE52V2WD15
FIGI: BBG00H0LX7J3
13 reports from 2019 to 2025
